Senores Pharmaceuticals IPO Allotment Status: How to Check Online via Link Intime, NSE & BSE; Latest GMP Updates

Key Takeaways:

• Allotment Status: The allotment for Senores Pharmaceuticals’ IPO is scheduled for December 26, 2024.
• Checking Allotment: Investors can verify their allotment status through Link Intime, NSE, and BSE platforms.
• Grey Market Premium (GMP): As of December 25, 2024, the IPO’s GMP is ₹240, indicating a potential listing price of ₹631 per share.

---

Senores Pharmaceuticals IPO Allotment Status: How to Check Online via Link Intime, NSE & BSE; Latest GMP Updates

Senores Pharmaceuticals Limited, a prominent player in the pharmaceutical industry, recently concluded its Initial Public Offering (IPO) subscription period from December 20 to December 24, 2024. The IPO received an overwhelming response, being oversubscribed by over 68 times on the final day.

Allotment Status and Dates

The basis of allotment is scheduled for December 26, 2024. Subsequently, refunds will be initiated on December 27, 2024, with shares expected to be credited to investors’ demat accounts on the same day. The company’s shares are slated to list on the BSE and NSE on December 30, 2024.

How to Check Allotment Status Online

Investors can check their allotment status through the following platforms:

1. Link Intime (Registrar’s Website):
   • Visit the Link Intime website.
   • Select ‘Senores Pharmaceuticals Limited’ from the dropdown menu.
   • Choose one of the following identification methods:
     • PAN: Enter your Permanent Account Number.
     • Application Number: Provide your IPO application number.
     • DP/Client ID: Input your Depository Participant and Client ID.
   • Click on ‘Search’ to view your allotment status.
2. NSE (National Stock Exchange):
   • Navigate to the NSE website.
   • Go to the ‘Investors’ section and select ‘IPO Allotment Status.’
   • Enter the required details, such as PAN or application number, to access your allotment information.
3. BSE (Bombay Stock Exchange):
   • Access the BSE website.
   • Under the ‘Investors’ tab, click on ‘Status of Issue Application.’
   • Select ‘Equity’ and choose ‘Senores Pharmaceuticals Limited’ from the list.
   • Enter your application number and PAN to view the allotment status.

Grey Market Premium (GMP) Insights

The Grey Market Premium (GMP) serves as an indicator of the market’s perception of the IPO’s potential performance. As of December 25, 2024, Senores Pharmaceuticals’ IPO commands a GMP of ₹240. Considering the upper price band of ₹391 per share, this suggests an estimated listing price of approximately ₹631, implying a potential gain of 61.4% per share.

Company Financials at a Glance

• FY 2023-24:
  • Revenue: ₹217.34 crore
  • Profit After Tax (PAT): ₹32.71 crore
• FY 2022-23:
  • Revenue: ₹39.02 crore
  • PAT: ₹8.43 crore

For the six-month period ending September 30, 2024, the company reported revenue of ₹185.35 crore and a PAT of ₹23.94 crore, reflecting a significant upward trajectory.

Investor Considerations

While the GMP offers insights into market sentiment, it is essential for investors to conduct comprehensive due diligence and consider their financial objectives before making investment decisions.

Disclaimer: This article is for informational purposes only. Investors are advised to consult with their financial advisors before making investment decisions.